Evaluate the taxable income for Pfizer Inc. for the fiscal year ending December 31, 2023. Start by considering the company's total revenue of $1,200,000,000 and deduct its cost of goods sold, which amounted to $500,000,000. Then, account for operating expenses totaling $350,000,000, followed by depreciation expenses of $60,000,000 and interest expenses of $22,000,000. With a corporate tax rate of 19%, compute the taxable income for Pfizer Inc.